Pharmacogenomics aims to develop coherent means to modify drug therapy, with respect to the patients' genotype, to ensure maximum efficiency with minimal contrary effects. Pharmacoproteomics is the “all-encompassing” analysis of the protein complement of the genome of an organism, is becoming an increasingly important discipline for the identification of disease targets and drug designing.
Open Access
Journal of Pharmacogenomics & Pharmacoproteomics (JPP) under open access category is peer-reviewed, freely available, easy to access, reliable and efficient source to spread the divine knowledge of researchers in the field of biotechnology, pharmacy, bioinformatics and other life science areas.
Editorial Manager
JPP is using online manuscript submission, review and tracking systems of Editorial Manager® for quality and quick review processing. Review processing is performed by the editorial board members of JPP or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript.
International Prospectives
JPP would address the issues and provide the reader with the essentials of the science and theory behind these disciplines, also giving practical applications of various methods for better understanding of modern drug design and development.
Applying for a waiver or discount please e-mail(info@omicsonline.org) to the managing editor with proposed title and abstract.
